Clinical trials
Withdrawn Phase 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Bristol-Myers Squibb | 2 |
| Hoffmann-La Roche | 2 |
| Imperial College London | 2 |
| Queen Mary University of London | 2 |
| Sangart | 2 |
| University of Edinburgh | 2 |
| 4D pharma plc | 1 |
| Arbutus Biopharma Corporation | 1 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 3 |
| Breast Neoplasms | 2 |
| Colitis, Ulcerative | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Lymphoma | 2 |
| Multiple Sclerosis | 2 |
| Myelodysplastic Syndromes | 2 |
| Scleroderma, Diffuse | 2 |
| Acidosis, Lactic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.